Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Updates from AMA House of Delegates 2023 Interim Meeting

From the College  |  December 12, 2023

The resolution supported by ACR and passed by the HOD will have the AMA prioritize improving Medicaid payment rates due to their critical impact on patient care and patient access to care. Additionally, it 1) adds to AMA policy new support for demonstration projects, carve outs and adjustments for pediatric patients and services provided to pediatric patients within the payment reform arena; 2) calls for the AMA to work with societies on payment models and to call for related payment models to be developed by the Center for Medicare & Medicaid Innovation (CMMI); 3) will have the AMA support appropriate demonstration projects, carve outs and adjustments for pediatric patients and services provided to pediatric patients within the payment reform arena; and 4) will have the AMA support and collaborate with state and national medical specialty societies and other interested parties on the development and adoption of physician-developed alternative payment models for pediatric health care that address the distinct prevention and health needs of children.

Smoothing the Path for International Physicians

As with many other specialties experiencing workforce shortages in the United States, patients with rheumatic diseases depend in part on visa-holding physicians to provide high-quality care.  For the 2023 application cycle, about one third of applicants to pediatric rheumatology fellowship programs and over one half of applicants to adult rheumatology fellowship programs were graduates of non-U.S. medical schools, many of whom rely on a J-1 visa for their fellowship training years. Providing a viable path for practice in the U.S. for these highly qualified physicians will be crucial to ensuring future quality care for patients across the country.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

These issues were addressed in Resolution 217, “Addressing Work Requirements for J-1 Visa Waiver Physicians,” which was introduced by the International Medical Graduates Section and strongly supported during the meeting by the ACR’s delegation. This resolution would have the AMA advocate for a revision in the J-1 waiver physician’s requirement, proposing a transition to a comprehensive 40-hour work requirement that encompasses both direct clinical responsibilities and other professional activities, acknowledging the reality of clinical practice. This resolution will move forward through referral to the AMA Board of Trustees, which will report back with recommendations at a future HOD meeting.

The ACR thanks all members who contribute to these efforts by joining or maintaining membership in the AMA. This allows the ACR to retain representation in the AMA House of Delegates and related critical policy bodies, including the AMA Relative Value Scale Update Committee (RUC) and AMA Current Procedural Terminology (CPT) policy groups. Maintain your AMA membership each year to take advantage of AMA member benefits and sustain rheumatology’s continued representation.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 | Single Page
Share: 

Filed under:Legislation & Advocacy Tagged with:AMA House of Delegates (HOD)

Related Articles

    Rheumatology Priorities Advanced at Busy AMA House of Delegates Meeting

    June 16, 2023

    Two ACR-led resolutions on in-office specialty drug dispensing and the proposed NIH Public Access Plan passed the House of Delegates and will become AMA policy.

    Keep ACR’s Advocacy Voice Strong with the American Medical Association

    July 6, 2022

    As the result of years of coalition work with partners at the AMA, the ACR recently celebrated a major advocacy win when the FTC announced an investigation of PBM business practices. Join or renew your AMA membership before Sept. 1 so the ACR can keep delegate seats to drive action within the AMA.

    ACR Scores Wins for Rheumatology Community at AMA House of Delegates Interim Meeting

    November 17, 2022

    Key successes for the rheumatology community secured by the ACR’s delegation include passage of the ACR’s resolution addressing pharmacy benefit administrators, advances in policies to protect rheumatologists and patients in the post-Dobbs landscape and retention of the rheumatology’s representation in the AMA House of Delegates.

    The ACR’s Representation in American Medical Association Critical as Review Looms

    March 17, 2017

    There is a saying that if the American Medical Association (AMA) did not exist, we would have to invent it. That is just what Dr. Nathan S. Davis did back in 1845 when he called for a national medical convention and laid the foundation for the establishment of the AMA in 1847. This new group would…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences